Effect of 15-deoxyspergualin in islet xenograft rejection.
Yoshimura
A
A
First Department of Surgery, Nara Medical University, Japan.
Nakajima
Y
Y
Kanehiro
H
H
Nakano
H
H
D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D000917:Antibody Formation / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D006224:Cricetinae; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006146:Guanidines / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000379:methods; D008297:Male; D008647:Mesocricetus; D051381:Rats; D017208:Rats, Wistar; D012086:Reoperation; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000379:methods
D000910:Antibodies, Heterophile; D001786:Blood Glucose; D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus